Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-25 5:06 pm Unchanged | 2025-09-22 | 13D | vTv Therapeutics Inc. VTVT | Samsara BioCapital, L.P. | 343,223 9.900% | 0 (Unchanged) | Filing History |
| 2025-09-08 6:00 pm Purchase | 2025-08-29 | 13G | vTv Therapeutics Inc. VTVT | Trails Edge Capital Partners, LP | 340,536 9.900% | 340,536 (New Position) | Filing History |
| 2025-09-08 5:43 pm Purchase | 2025-08-29 | 13G | vTv Therapeutics Inc. VTVT | Invus Public Equities, L.P. | 348,083 9.990% | 348,083 (New Position) | Filing History |
| 2025-09-03 7:33 pm Purchase | 2025-08-29 | 13D | vTv Therapeutics Inc. VTVT | Samsara BioCapital, L.P. | 343,223 9.900% | 77,603 (+29.22%) | Filing History |
| 2024-11-12 10:40 am Purchase | 2024-11-08 | 13G | vTv Therapeutics Inc. VTVT | FMR LLC | 178,200 7.324% | 178,200 (New Position) | Filing History |
| 2024-03-22 4:57 pm Purchase | 2024-02-27 | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 1,535,685 50.300% | 1,535,685 (New Position) | Filing History |
| 2024-03-05 7:52 pm Purchase | 2024-02-27 | 13D | vTv Therapeutics Inc. VTVT | Samsara BioCapital, L.P. | 265,620 10.400% | 265,620 (New Position) | Filing History |
| 2024-03-05 4:24 pm Purchase | 2024-02-27 | 13D | vTv Therapeutics Inc. VTVT | Baker Bros. Advisors LP | 122,664 4.990% | 122,664 (New Position) | Filing History |
| 2022-08-23 3:10 pm Purchase | 2022-08-16 | 13G | vTv Therapeutics Inc. VTVT | Medpace Investors LLC | 134,938 5.160% | 134,938 (New Position) | Filing History |
| 2022-06-10 4:15 pm Purchase | 2022-05-31 | 13D | vTv Therapeutics Inc. VTVT | G42 Investments AI Holdings RSC Ltd. | 259,657 13.400% | 259,657 (New Position) | Filing History |
| 2022-06-01 4:05 pm Sale | 2022-05-31 | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 1,535,685 60.100% | -2,175 (-0.14%) | Filing History |
| 2021-11-12 4:46 pm Unchanged | 2021-11-09 | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 1,537,860 67.000% | 0 (Unchanged) | Filing History |
| 2021-09-17 4:01 pm Purchase | 2021-02-24 | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 1,537,860 72.300% | 1,537,860 (New Position) | Filing History |
| 2020-12-17 5:02 pm Unchanged | 2020-12-17 | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 1,537,860 79.300% | 0 (Unchanged) | Filing History |
| 2020-12-10 4:45 pm Unchanged | 2020-12-10 | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 1,537,860 79.300% | 0 (Unchanged) | Filing History |
| 2020-11-24 4:45 pm Unchanged | 2020-11-24 | 13D | vTv Therapeutics Inc. VTVT | MacAndrews & Forbes Inc. | 1,537,860 79.300% | 0 (Unchanged) | Filing History |